IMAB
I-Mab
NASDAQ · Healthcare · Biotechnology · US
$2.88
−0.69%Institutional positioning
13F filings over the trailing two quarters
New 0Increased 0Reduced 0Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GOLDMAN SACHS GROUP INC | Sold Out | 0 | Mar 25, 2026 |
| Candriam S.C.A. | Sold Out | 0 | Apr 30, 2026 |
| MORGAN STANLEY | Sold Out | 0 | May 27, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings